Sanofi (SNY) Amortizatization of Intangibles (2024 - 2026)

Sanofi's (SNY) quarterly Amortizatization of Intangibles came in at -$626.3 million in Q1 2026, down 49.24% year-on-year from -$1.2 billion in Q1 2025, and up 69.7% quarter-over-quarter from -$2.1 billion in Q4 2025.

Sanofi (SNY) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends

Sanofi has disclosed Amortizatization of Intangibles across 3 years of filings, most recently posting -$626.3 million for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at -$626.3 million, down 49.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.0 billion (changed N/A YoY), and the FY2025 annual result was -$2.1 billion, down 10.61% from the prior year.
  • Amortizatization of Intangibles came in at -$626.3 million for Q1 2026 at Sanofi, up from -$2.1 billion in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of -$419.7 million in Q1 2025 to a low of -$2.1 billion in Q4 2025.
  • The 3-year median for Amortizatization of Intangibles is -$1.2 billion (2026), against an average of -$1.2 billion.
  • Across the five-year window, Amortizatization of Intangibles decreased 10.61% in 2025 and plunged 49.24% in 2026, its largest moves.
  • Sanofi's Amortizatization of Intangibles stood at -$1.9 billion in 2024, then slipped by 10.61% to -$2.1 billion in 2025, then soared by 69.7% to -$626.3 million in 2026.
  • The last three Amortizatization of Intangibles figures came in at -$626.3 million (Q1 2026), -$2.1 billion (Q4 2025), and -$419.7 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 1.70 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 931.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 596.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Sanofi 63.47 Mn -6.87 Bn 9.49 Bn -626.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -626.35 Mn
Mar 31, 2026 -626.35 Mn
Dec 31, 2025 -2.07 Bn
Dec 31, 2025 -2.07 Bn
Mar 31, 2025 -419.70 Mn
Mar 31, 2025 -419.70 Mn
Dec 31, 2024 -1.87 Bn
Dec 31, 2024 -1.87 Bn